C5orf46
gene geneOn this page
Also known as MGC23985SSSP1AP-64
Summary
C5orf46 (chromosome 5 open reading frame 46, HGNC:33768) is a protein-coding gene on chromosome 5q32, encoding Uncharacterized protein C5orf46 (Q6UWT4).
Located in extracellular exosome.
Source: NCBI Gene 389336 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 9 total — 3 pathogenic
- MANE Select transcript:
NM_206966
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33768 |
| Approved symbol | C5orf46 |
| Name | chromosome 5 open reading frame 46 |
| Location | 5q32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC23985, SSSP1, AP-64 |
| Ensembl gene | ENSG00000178776 |
| Ensembl biotype | protein_coding |
| Entrez | 389336 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000318315, ENST00000510432, ENST00000515291, ENST00000955897, ENST00000955898
RefSeq mRNA: 1 — MANE Select: NM_206966
NM_206966
CCDS: CCDS34267
Canonical transcript exons
ENST00000318315 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001238658 | 147906432 | 147906538 |
| ENSE00001416461 | 147892722 | 147892939 |
| ENSE00001417308 | 147896984 | 147897041 |
| ENSE00003620716 | 147901629 | 147901773 |
Expression profiles
Bgee: expression breadth ubiquitous, 147 present calls, max score 98.74.
FANTOM5 (CAGE): breadth broad, TPM avg 6.5005 / max 570.7692, expressed in 446 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 64084 | 6.5005 | 446 |
Top tissues by expression
238 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 98.74 | gold quality |
| upper leg skin | UBERON:0004262 | 97.63 | gold quality |
| penis | UBERON:0000989 | 96.99 | gold quality |
| skin of leg | UBERON:0001511 | 96.05 | gold quality |
| zone of skin | UBERON:0000014 | 95.77 | gold quality |
| skin of abdomen | UBERON:0001416 | 95.66 | gold quality |
| ascending aorta | UBERON:0001496 | 95.62 | gold quality |
| thoracic aorta | UBERON:0001515 | 95.17 | gold quality |
| skin of hip | UBERON:0001554 | 93.30 | gold quality |
| mammalian vulva | UBERON:0000997 | 92.69 | gold quality |
| parotid gland | UBERON:0001831 | 91.94 | gold quality |
| nipple | UBERON:0002030 | 89.37 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 86.80 | gold quality |
| right coronary artery | UBERON:0001625 | 86.02 | gold quality |
| aorta | UBERON:0000947 | 85.06 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 84.22 | gold quality |
| apex of heart | UBERON:0002098 | 83.95 | gold quality |
| left testis | UBERON:0004533 | 82.73 | gold quality |
| right testis | UBERON:0004534 | 82.35 | gold quality |
| saphenous vein | UBERON:0007318 | 81.35 | gold quality |
| minor salivary gland | UBERON:0001830 | 81.21 | gold quality |
| left coronary artery | UBERON:0001626 | 79.73 | gold quality |
| testis | UBERON:0000473 | 79.54 | gold quality |
| coronary artery | UBERON:0001621 | 79.27 | gold quality |
| heart left ventricle | UBERON:0002084 | 78.69 | gold quality |
| cardiac ventricle | UBERON:0002082 | 78.21 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 77.98 | gold quality |
| popliteal artery | UBERON:0002250 | 77.58 | gold quality |
| mouth mucosa | UBERON:0003729 | 77.54 | gold quality |
| tibial artery | UBERON:0007610 | 77.53 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.45 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting C5orf46, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-609 | 99.82 | 64.26 | 505 |
| HSA-MIR-6762-3P | 99.66 | 66.94 | 1188 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-6165 | 99.44 | 67.12 | 1389 |
| HSA-MIR-4721 | 99.26 | 66.05 | 818 |
| HSA-MIR-4324 | 99.04 | 70.14 | 1569 |
| HSA-MIR-7843-3P | 98.31 | 67.94 | 803 |
| HSA-MIR-124-5P | 98.11 | 67.65 | 1095 |
| HSA-MIR-6842-3P | 98.07 | 66.33 | 1325 |
| HSA-MIR-3650 | 97.88 | 64.89 | 693 |
| HSA-MIR-7154-3P | 97.65 | 65.02 | 985 |
| HSA-MIR-148B-5P | 97.29 | 66.30 | 992 |
| HSA-MIR-6874-3P | 97.29 | 66.34 | 975 |
| HSA-MIR-505-5P | 97.01 | 65.54 | 778 |
| HSA-MIR-1226-5P | 96.50 | 65.28 | 643 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gm94 | ENSMUSG00000071858 |
| rattus_norvegicus | C18h5orf46 | ENSRNOG00000039260 |
Protein
Protein identifiers
Uncharacterized protein C5orf46 — Q6UWT4 (reviewed: Q6UWT4)
All UniProt accessions (1): Q6UWT4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6UWT4-1 | 1 | yes |
| Q6UWT4-2 | 2 |
RefSeq proteins (1): NP_996849* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027950 | DUF4576 | Family |
Pfam: PF15144
UniProt features (6 total): signal peptide 1, chain 1, region of interest 1, splice variant 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6UWT4-F1 | 64.94 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 36 (showing top):
SENESE_HDAC1_AND_HDAC2_TARGETS_DN, FREAC3_01, TGACATY_UNKNOWN, CREB_Q2_01, chr5q32, MYC_UP.V1_UP, GATA1_05, LHX9_TARGET_GENES, MIR548E_5P, MIR6124, GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN, GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN, MIR505_5P, GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN, GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): extracellular exosome (GO:0070062), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| extracellular vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
272 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C5orf46 | WFDC5 | Q8TCV5 | 479 |
| C5orf46 | MUCL1 | Q96DR8 | 445 |
| C5orf46 | ADGRF4 | Q8IZF3 | 433 |
| C5orf46 | GPR87 | Q9BY21 | 420 |
| C5orf46 | SUMO4 | Q6EEV6 | 420 |
| C5orf46 | CDHR1 | Q96JP9 | 419 |
| C5orf46 | LYNX1 | P0DP58 | 397 |
| C5orf46 | SUMO2 | P55855 | 389 |
| C5orf46 | SERPINB7 | O75635 | 380 |
| C5orf46 | TMEM45A | Q9NWC5 | 362 |
| C5orf46 | WFDC12 | Q8WWY7 | 358 |
| C5orf46 | MYOCOS | A0A1B0GUC4 | 349 |
| C5orf46 | C9J5N1 | C9J5N1 | 323 |
| C5orf46 | MAGEB6 | Q8N7X4 | 323 |
| C5orf46 | AARSD1 | Q9BTE6 | 320 |
IntAct
41 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C5orf46 | TMBIM6 | psi-mi:“MI:0914”(association) | 0.560 |
| C5orf46 | TBXA2R | psi-mi:“MI:0915”(physical association) | 0.560 |
| C5orf46 | LHFPL5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SGTA | C5orf46 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C5orf46 | SLC30A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C5orf46 | SGTB | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP6 | C5orf46 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBXA2R | C5orf46 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PEX12 | C5orf46 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C5orf46 | TMEM80 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C5orf46 | TIMMDC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C5orf46 | RUSF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C5orf46 | FAM210B | psi-mi:“MI:0915”(physical association) | 0.560 |
| EBP | C5orf46 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C5orf46 | TMBIM6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C5orf46 | SGTA | psi-mi:“MI:0915”(physical association) | 0.000 |
| C5orf46 | SLC30A2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C5orf46 | SGTB | psi-mi:“MI:0915”(physical association) | 0.000 |
| C5orf46 | PEX12 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C5orf46 | TMEM80 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C5orf46 | TIMMDC1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C5orf46 | RUSF1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C5orf46 | FAM210B | psi-mi:“MI:0915”(physical association) | 0.000 |
| C5orf46 | AQP6 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (17): PPCS (Affinity Capture-MS), TMBIM6 (Affinity Capture-MS), C5orf46 (Two-hybrid), C5orf46 (Two-hybrid), C5orf46 (Two-hybrid), C5orf46 (Two-hybrid), C5orf46 (Two-hybrid), C5orf46 (Two-hybrid), C5orf46 (Two-hybrid), C5orf46 (Two-hybrid), C5orf46 (Two-hybrid), C5orf46 (Two-hybrid), LHFPL5 (Two-hybrid), SGTB (Two-hybrid), C5orf46 (Positive Genetic)
ESM2 similar proteins: A0A1S4FQ37, A0A6B9L4T1, A2XAM1, A3KQQ9, A3RGB1, A6QLI2, D1FQ14, F5HF90, F7E728, H2A0M1, H7C7P1, O01949, O94356, P04923, P04926, P08725, P13828, P16845, P32778, P36046, P47868, P53278, P86958, Q02448, Q04807, Q19970, Q3T146, Q3V2D2, Q45206, Q45214, Q45215, Q54IN6, Q5MIT9, Q6R7H2, Q6UWT4, Q7YT37, Q8SRT0, Q8SV33, Q8SWP0, Q8T117
Diamond homologs: Q3T146, Q3V2D2, Q6UWT4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
9 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 3 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 147500 | GRCh38/hg38 5q32(chr5:145197355-148541511)x1 | Pathogenic |
| 2685176 | GRCh37/hg19 5q32(chr5:147165102-147600692)x1 | Pathogenic |
| 3246298 | NC_000005.9:g.(?147204224)(147516554_?)del | Pathogenic |
SpliceAI
606 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:147881444:A:AG | acceptor_gain | 1.0000 |
| 5:147881445:G:GA | acceptor_gain | 1.0000 |
| 5:147881445:GCT:G | acceptor_gain | 1.0000 |
| 5:147881445:GCTA:G | acceptor_gain | 1.0000 |
| 5:147881594:G:GT | donor_gain | 1.0000 |
| 5:147901623:GCTTA:G | donor_loss | 1.0000 |
| 5:147901624:CTT:C | donor_loss | 1.0000 |
| 5:147901625:TTAC:T | donor_loss | 1.0000 |
| 5:147901626:TA:T | donor_loss | 1.0000 |
| 5:147901627:A:AC | donor_gain | 1.0000 |
| 5:147901627:ACG:A | donor_loss | 1.0000 |
| 5:147901628:C:CC | donor_gain | 1.0000 |
| 5:147901628:CGTG:C | donor_gain | 1.0000 |
| 5:147901771:CGT:C | acceptor_gain | 1.0000 |
| 5:147901773:TC:T | acceptor_loss | 1.0000 |
| 5:147901774:C:CA | acceptor_loss | 1.0000 |
| 5:147901775:T:G | acceptor_loss | 1.0000 |
| 5:147881442:GCA:G | acceptor_loss | 0.9900 |
| 5:147881443:CAG:C | acceptor_loss | 0.9900 |
| 5:147881445:GC:G | acceptor_gain | 0.9900 |
| 5:147881445:GCTAC:G | acceptor_gain | 0.9900 |
| 5:147881586:GGGC:G | donor_gain | 0.9900 |
| 5:147881683:G:T | donor_gain | 0.9900 |
| 5:147892939:CCTT:C | acceptor_gain | 0.9900 |
| 5:147892942:T:C | acceptor_gain | 0.9900 |
| 5:147892942:T:TC | acceptor_gain | 0.9900 |
| 5:147892955:C:CT | acceptor_gain | 0.9900 |
| 5:147901627:ACGTG:A | donor_gain | 0.9900 |
| 5:147901628:CGTGC:C | donor_gain | 0.9900 |
| 5:147901631:G:A | donor_gain | 0.9900 |
AlphaMissense
567 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:147901666:C:G | A60P | 0.974 |
| 5:147906465:C:G | G13R | 0.974 |
| 5:147906465:C:T | G13R | 0.974 |
| 5:147901687:C:G | G53R | 0.972 |
| 5:147901686:C:T | G53D | 0.970 |
| 5:147901700:G:C | F48L | 0.968 |
| 5:147901700:G:T | F48L | 0.968 |
| 5:147901702:A:G | F48L | 0.968 |
| 5:147901677:A:G | I56T | 0.955 |
| 5:147901677:A:C | I56S | 0.954 |
| 5:147901687:C:A | G53C | 0.950 |
| 5:147906464:C:T | G13E | 0.946 |
| 5:147901698:A:T | L49Q | 0.944 |
| 5:147901665:G:T | A60E | 0.943 |
| 5:147901674:A:T | I57N | 0.941 |
| 5:147901686:C:A | G53V | 0.941 |
| 5:147901701:A:C | F48C | 0.931 |
| 5:147901662:A:T | V61D | 0.930 |
| 5:147901698:A:G | L49P | 0.929 |
| 5:147901698:A:C | L49R | 0.925 |
| 5:147901701:A:G | F48S | 0.917 |
| 5:147901677:A:T | I56N | 0.904 |
| 5:147901707:G:A | P46L | 0.900 |
| 5:147901650:A:G | L65P | 0.891 |
| 5:147901655:G:C | F63L | 0.890 |
| 5:147901655:G:T | F63L | 0.890 |
| 5:147901657:A:G | F63L | 0.890 |
| 5:147901656:A:G | F63S | 0.888 |
| 5:147901653:A:T | I64N | 0.887 |
| 5:147901707:G:T | P46H | 0.877 |
dbSNP variants (sampled 300 via entrez): RS1000062454 (5:147905047 T>C), RS1000318734 (5:147893023 C>A,T), RS1000434750 (5:147905217 G>A), RS1000510319 (5:147903975 T>C), RS1000541279 (5:147908535 C>A,T), RS1000711172 (5:147885680 CCA>C), RS1001058324 (5:147893427 G>A,C), RS1001080979 (5:147887243 C>G), RS1001143439 (5:147886955 G>A), RS1001201244 (5:147887613 C>T), RS1001359205 (5:147899653 C>T), RS1001416565 (5:147889447 T>C), RS1001639119 (5:147905912 A>G), RS1001813936 (5:147907304 T>C), RS1001831346 (5:147893547 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (1): ichthyosis linearis circumflexa (MONDO:0043106)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004860_95 | Alcoholic chronic pancreatitis | 3.000000e-15 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | decreases expression | 2 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| trichostatin A | increases expression | 1 |
| clothianidin | increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Oxygen | increases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Valproic Acid | decreases expression, increases methylation | 1 |
| Cyclosporine | decreases expression | 1 |
| Sodium Selenite | decreases expression | 1 |
| Lactic Acid | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): ichthyosis linearis circumflexa